These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31251928)

  • 1. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
    Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
    Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
    Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
    Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
    Butt AA; Yan P; Shaikh OS; Lo Re V; Abou-Samra AB; Sherman KE
    J Hepatol; 2020 Aug; 73(2):277-284. PubMed ID: 32145260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular outcomes and all-cause mortality in patients with chronic hepatitis B and C: A 13-year nationwide population-based study in Asia.
    Wu VC; Chen TH; Wu M; Cheng CW; Chen SW; Chang CW; Chen CC; Chang SH; Hung KC; Chern MS; Lin FC; Chu PH; Wu CS
    Atherosclerosis; 2018 Feb; 269():178-184. PubMed ID: 29366991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past exposure to hepatitis B: a risk factor for increase in mortality?
    Jinjuvadia R; Liangpunsakul S; Antaki F
    J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.
    Ly KN; Xing J; Klevens RM; Jiles RB; Ward JW; Holmberg SD
    Ann Intern Med; 2012 Feb; 156(4):271-8. PubMed ID: 22351712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
    Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
    J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
    Allaire M; Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; DI Martino V; Sutton A; Letouzé E; Audureau E; Roudot-Thoraval F;
    Hepatology; 2018 Oct; 68(4):1245-1259. PubMed ID: 29663511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
    Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
    J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data.
    Fedeli U; Grande E; Grippo F; Frova L
    World J Gastroenterol; 2017 Mar; 23(10):1866-1871. PubMed ID: 28348493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States.
    Kim D; Alshuwaykh OS; Cholankeril G; Wong RJ; Ahmed A
    J Viral Hepat; 2021 Feb; 28(2):436-439. PubMed ID: 33147365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
    Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
    Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations.
    Kim D; Li AA; Perumpail RB; Cholankeril G; Gonzalez SA; Kim W; Ahmed A
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1607-1615.e2. PubMed ID: 30391436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Stepanova M; Rafiq N; Younossi ZM
    Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
    Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.